Investor · South San Francisco, CA

Ilan Zipkin

Open Ilan in the network graph →

Filings

29

SEC Form D

Connections

144

co-filers

Capital

$89.5M

across filings

Active

May 2018

to Sep 2021

Most-connected co-filers (144)

David Lockhart · Cranbury, NJ7 shared Joe Kiani · Irvine, CA6 shared David E. Pyott · Irvine, CA6 shared Nina H. Kjellson · Denver, CO5 shared Jason Chen · New York, NY5 shared L. P. Gage · Watertown, MA5 shared Frank Foster · Santa Barbara, CA5 shared David Lamond · San Francisco, CA5 shared Gaurav Aggarawal · San Carlos, CA5 shared Bill Bennett · Evanston, IL5 shared David Southern · San Carlos, CA5 shared Michael J. Powell · Billerica, MA5 shared William R. Ringo · Menlo Park, CA5 shared Miguel De Los Rios · San Diego, CA5 shared Stephen A. Dominy · South San Francisco, CA5 shared Margi Mcloughlin · South San Francisco, CA5 shared Casey Lynch · South San Francisco, CA5 shared Kristen Gafric · South San Francisco, CA5 shared Michael R. Markunas · Los Angeles, CA4 shared Daphne Zohar · Boston, MA4 shared Melissa T. Heim · Portland, OR4 shared Edward Mathers · Cambridge, MA4 shared Charles P. Keates · Newtown Square, PA4 shared Barry Funt · New York, NY4 shared

Recent filings (29)

Via Nova Therapeutics, Inc.Sep 2021 · 7 co-filers$5.0M Via Nova Therapeutics, Inc.Sep 2021 · 7 co-filers$5.0M Aditum Bio Fund 2, L.P.Jul 2021 · 12 co-filers$250.0M Aditum Bio Fund 2, L.P.Jul 2021 · 12 co-filers$250.0M Cortexyme, Inc.May 2018 · 13 co-filers$85.6M Cortexyme, Inc.May 2018 · 13 co-filers$85.6M Bioniz Therapeutics, Inc.Apr 2017 · 11 co-filers$18.6M Bioniz Therapeutics, Inc.Apr 2017 · 11 co-filers$18.6M Epica International, Inc.Mar 2017 · 21 co-filers$5.0M Cortexyme, Inc.Feb 2017 · 19 co-filers$8.0M Bioniz Therapeutics, Inc.Aug 2016 · 11 co-filers$15.0M ENDEAVOR SCHOOLS, LLCJul 2016 · 22 co-filers$10.0M Bioniz Therapeutics, Inc.Apr 2016 · 13 co-filers$15.0M Cortexyme, Inc.Jan 2016 · 17 co-filers$15.9M Epica International, Inc.Nov 2015 · 21 co-filers$5.0M ENDEAVOR SCHOOLS, LLCJul 2015 · 22 co-filers$14.0M ALVINE PHARMACEUTICALS INCOct 2011 · 20 co-filers$12.0M ALVINE PHARMACEUTICALS INCMar 2011 · 15 co-filers$26.5M Axtria, Inc.Jan 2011 · 5 co-filers$4.5M SATORI PHARMACEUTICALS INCJan 2011 · 13 co-filers$20.7M Chimeros IncDec 2010 · 8 co-filers$750K Chimeros IncOct 2010 · 7 co-filers$500K Chimeros IncJul 2010 · 7 co-filers$500K Axtria, Inc.May 2010 · 5 co-filers$2.5M Chimeros IncApr 2010 · 8 co-filers$500K

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Ilan in the interactive graph →